MDM4 amplification is a possible mechanism for functional inactivation of the p53 pathway in Ewing Sarcoma given the infrequent occurrences of MDM2 amplification, CDKN2A deletion, or TP53 mutation in these cancers. Here, CDKN2A is linked to Ewing sarcoma.